El interés en corto de Marsh & McLennan Cos da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Marsh & McLennan Cos. Los datos de interés en corto se actualizan cada dos semanas.

Marsh & McLennan Cos (NYSE:MMC) Bolsa, Informe de interés en corto

MARSH & MCLENNAN COS

Marsh & McLennan

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Companies Inc

NYLI MacKay California Muni Intermediate ETF

Members Co Ltd

MAG MILE CAPITAL,INC by Mag Mile Capital Inc.

Mag Mile Capital Inc

Andean Silver Ltd

Mind Medicine Inc Warrants(11/12/2023)

Marsh McLennan Agency (MMA), a business of Marsh and a leading provider of business insurance, employee health and benefits, retirement and wealth, and private client insurance solutions across the US and Canada, today announced the acquisition of Arthur Hall Insurance, a West Chester, Pennsylvania-based full-service insurance agency. Terms of the acquisition were not disclosed.
Founded in 1966, Arthur Hall provides commercial and personal lines expertise to clients across the country, with specialties in the life sciences, information management, non-profit, craft beverage manufacturing, and municipal industries. All Arthur Hall employees, including President Jim Denham, will join MMA and continue to operate out of their two office locations in West Chester and Wilmington, Delaware.
"Our clients are facing challenges on multiple fronts, and our value lies in the ability to foresee these dynamics and equip them for any scenario," said Andrew Neary, CEO of MMA's East region. "We look forward to bringing the Arthur Hall team's business insurance expertise to our clients in the region, while simultaneously establishing a new presence for MMA in Delaware."
Mr. Denham added: "MMA has a unique power of perspective that is unmatched in the industry. In our ongoing pursuit of enhancing client outcomes, it became clear that joining MMA was our best path forward for our clients and colleagues, providing access to a wide range of risk mitigation strategies and a network of experts for clients and resources to enhance our colleagues' careers."

News

Marsh McLennan Agency Acquires Arthur Hall Insurance; Terms Not Disclosed

Marsh &amp; McLennan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has risen 3.88% since its last report. The company recently reported that it has 5.42 million shares sold short, which is 1.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742916622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Marsh &amp; McLennan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Marsh &amp; McLennan's peer group average for short interest as a percentage of float is 2.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Is Marsh & McLennan Gaining or Losing Market Support?

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 20 years by 6.49% on an annualized basis producing an average annual return of 14.71%. Currently, Marsh &amp; McLennan has a market capitalization of $114.62 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 20 years ago, it would be worth $1,555.80 today based on a price of $233.37 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742503514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

In the current session, the stock is trading at $231.01, after a 0.47% spike. Over the past month, Marsh &amp; McLennan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) stock increased by 0.93%, and in the past year, by 11.63%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1741967125_0.png" alt="Past Year Chart" />

<h3>Marsh &amp; McLennan P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Marsh &amp; McLennan has a lower P/E than the aggregate P/E of 39.85 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1741967125_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Marsh & McLennan

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 4.59% on an annualized basis producing an average annual return of 16.51%. Currently, Marsh &amp; McLennan has a market capitalization of $113.24 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 15 years ago, it would be worth $994.36 today based on a price of $230.57 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740153636_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Marsh &amp; McLennan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has risen 8.51% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.99 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739982612_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Marsh &amp; McLennan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Marsh &amp; McLennan's peer group average for short interest as a percentage of float is 2.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Marsh & McLennan's Recent Short Interest

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.mercer.com%2Fen-us%2F&amp;esheet=54208762&amp;newsitemid=20250218628692&amp;lan=en-US&amp;anchor=Mercer&amp;index=1&amp;md5=67a51132d7d881771eee5b9717fac3e6">Mercer</a>, a business of Marsh McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, today announced that it reached an agreement to acquire SECOR Asset Management, a global provider of bespoke strategic and portfolio solutions. Terms of the transaction, which is expected to close in the second quarter of 2025, subject to regulatory approvals and client consents, were not disclosed.
Founded in 2010 by Tony Kao, Ray Iwanowski and partners, SECOR serves the complex needs of institutional investors, including pension funds, insurance companies, endowments and family offices, with a range of end-to-end portfolio solutions, including investment advisory and implementation, fiduciary management and asset liability management. It has $13.8 billion in assets under advisement and $21.5 billion in assets under management as of September 30, 20241.

Marsh McLennan's Mercer To Acquire SECOR Asset Management; No Financial Terms Disclosed

Raymond James analyst C. Gregory Peters reiterates Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Outperform and raises the price target from $240 to $250.

Price Target

Reiteration

Analyst Ratings

Raymond James Reiterates Outperform on Marsh & McLennan, Raises Price Target to $250

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and lowers the price target from $214 to $210.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan, Lowers Price Target to $210

Wells Fargo analyst Elyse Greenspan maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and raises the price target from $212 to $223.

Wells Fargo Maintains Equal-Weight on Marsh & McLennan, Raises Price Target to $223

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 3.31% on an annualized basis producing an average annual return of 14.71%. Currently, Marsh &amp; McLennan has a market capitalization of $107.24 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 10 years ago, it would be worth $396.21 today based on a price of $218.35 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738254609_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

Earnings

Earnings Beats

Marsh & McLennan Q4 2024 Adj. EPS $1.87 Beats $1.76 Estimate, Sales $6.067B Beat $5.946B Estimate

AAPL

ABCB

ALGM

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SCSC

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

Across the recent three months, 10 analysts have shared their insights on Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $235.8, a high estimate of $259.00, and a low estimate of $212.00. Surpassing the previous average price target of $228.11, the current average has increased by 3.37%.
<img src="https://www.benzinga.com/files/images/story/2025/1736535624_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Marsh &amp; McLennan. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Underperform</td>
<td>$214.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$235.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$242.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$242.00</td>
<td>-</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$246.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$228.00</td>
<td>$217.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$259.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Underperform</td>
<td>$212.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Harry Fong</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Neutral</td>
<td>$230.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$242.00</td>
<td>$232.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Marsh &amp; McLennan. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Marsh &amp; McLennan compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Marsh &amp; McLennan's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Marsh &amp; McLennan's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Marsh &amp; McLennan analyst ratings.</a>
<h2>Get to Know Marsh &amp; McLennan Better</h2>
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
<h3>Marsh &amp; McLennan: A Financial Overview</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Marsh &amp; McLennan's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 5.85%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Marsh &amp; McLennan's net margin excels beyond industry benchmarks, reaching 13.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Marsh &amp; McLennan's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Marsh &amp; McLennan's ROA stands out, surpassing industry averages. With an impressive ROA of 1.52%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.08.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 10 Analysts Discuss Marsh & McLennan Stock

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and raises the price target from $212 to $214.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan, Raises Price Target to $214

JP Morgan analyst Jimmy Bhullar maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $230 to $235.

JP Morgan Maintains Neutral on Marsh & McLennan, Raises Price Target to $235

Marsh & McLennan's Marsh McLennan Agency Acquires Acumen Solutions Group, Terms Not Disclosed

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 2.89% on an annualized basis producing an average annual return of 14.32%. Currently, Marsh &amp; McLennan has a market capitalization of $104.11 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 10 years ago, it would be worth $3,762.06 today based on a price of $211.98 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735658107_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 2.76% on an annualized basis producing an average annual return of 13.69%. Currently, Marsh &amp; McLennan has a market capitalization of $103.31 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 10 years ago, it would be worth $360.25 today based on a price of $210.35 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734647416_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today

RBC Capital analyst Scott Heleniak upgrades Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) from Sector Perform to Outperform and raises the price target from $242 to $250.

Upgrades

RBC Capital Upgrades Marsh & McLennan to Outperform, Raises Price Target to $250

Press Releases

Credit Benchmark and Oliver Wyman Launch IRB Nexus to Help Banks Improve Model Performance and Calibration

Despite Economic Uncertainty, US Employers Maintain Elevated Compensation Budgets for 2025, According to Mercer

Marsh McLennan Agency Acquires Acumen Solutions Group

Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30

Marsh McLennan Declares Quarterly Cash Dividend

Marsh McLennan Reports Strong Fourth Quarter and Full-Year 2024 Results

Marsh McLennan's Mercer to Acquire SECOR Asset Management

Marsh McLennan to Host First Quarter Earnings Investor Call on April 17

Marsh McLennan Agency Acquires Arthur Hall Insurance

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Marsh & McLennan Cos

Interés en corto

Marsh & McLennan Cos (NYSE:MMC) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL